---
date: "2024-01-01"
title: Second-line or maintainence therapy for idiopathic thrombocytopenic purpura
alias: 2L-Rx-ITP
---


- from: [[Treatment of Primary ITP in Adults]] 󰒖
- 
# Second-line or maintainence therapy for idiopathic thrombocytopenic purpura

![h:450px](https://i.imgur.com/lycJ6zF.png)

- Romiplostim, el/avatrombopag
  - [[TPO-R agonists]] → ↑ plt prod
- Rituximab (anti-CD20) ± dex
  - anti–B-cell Ab
- Splenectomy\* (less common)
  - ~65% long-term remission
- [[AZA]], 
- [[CYC]], 
- [[MMF]]
    - Immunosuppressants
- Danazol: 600 mg/d
    - Androgen (hirsutism) ↓ plt clearance
- [[fostamatinib.md|Fostamatinib]]

## Treatment algorithm for steroid dependent/unresponsive patients

![h:450px](https://i.imgur.com/ZGTQz1Q.png)

![h:450px](https://i.imgur.com/PF5yMJ1.png)
